Most sleep-focused protocols start DSIP at 50 to 100 micrograms subcutaneously, dosed 30 to 60 minutes before bed, within a broader community range of 50 to 400 micrograms. Human research on this peptide is thin, mostly intravenous, and decades old, and no FDA-approved DSIP product exists, so treat these numbers as a starting framework for a conversation with a prescriber, not a fixed prescription.